Abstract
Depression in people living with HIV/AIDS (PLWHA) is highly prevalent and related to worse adherence to antiretroviral therapy, but is amenable to change via CBT. Cognitive-behavioral therapy for adherence and depression (CBT-AD) specifically addresses negative automatic thoughts (ATs) as one component of the treatment. There is little research on the temporal nature of the relation between ATs and depression. HIV-positive adults with depression (N = 240) were randomized to CBT-AD, information/supportive psychotherapy for adherence and depression (ISP-AD), or one session of adherence counseling alone (ETAU). ATs were self-reported (Automatic Thoughts Questionnaire; ATQ) and depression was assessed by blinded interview (Montgomery-Asberg Depression Rating Scale; MADRS) at baseline, and 4-, 8-, and 12-months. We performed autoregressive cross-lagged panel models. Broadly, decreases in ATs were followed by decreases in depression, but decreases in depression were not followed by decreases in ATs. In CBT-AD, decreases in ATs were followed by decreases in depression, and vice versa. However, in the ISP group, while depression and ATs both significantly influenced each other, not all relations were in the direction expected. This study adds to the evidence base for cognitive interventions to decrease depression in individuals with a chronic medical condition, HIV/AIDS.




Similar content being viewed by others
References
Asch, S. M., Kilbourne, A. M., Gifford, A. L., Burnam, M. A., Turner, B., Shapiro, M. F., & Bozzette, S. A. (2003). Underdiagnosis of depression in HIV. Journal of General Internal Medicine, 18(6), 450–460.
Atkinson, J. H., & Grant, I. (1994). Natural history of neuropsychiatric manifestations of HIV disease. Psychiatric Clinics of North America, 17(1), 17–33.
Berrington, A., Smith, P., & Sturgis, P. (2006). An overview of methods for the analysis of panel data. Retrieved August 11, 2016 from http://eprints.ncrm.ac.uk/415.
Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721–728.
Brown, L. K., Kennard, B. D., Emslie, G. J., Mayes, T. L., Whiteley, L. B., Bethel, J., et al. (2016). Effective treatment of depressive disorders in medical clinics for adolescents and young adults living with HIV: A Controlled Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 71(1).
Ciesla, J. A., & Roberts, J. E. (2001). Meta-analysis of the relation between HIV infection and risk for depressive disorders. American Journal of Psychiatry, 158, 725–730.
Dew, M. A., Becker, J. T., Sanchez, J., Caldararo, R., Lopez, O. L., Wess, J., et al. (1997). Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: A longitudinal evaluation. Psychological Medicine, 27(2), 395–409.
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101–2107.
Forsyth, D. M., Poppe, K., Nash, V., Alarcon, R. D., & Kung, S. (2010). Measuring changes in negative and positive thinking in patients with depression: Measuring changes in negative and positive thinking in patients with depression. Perspectives in Psychiatric Care, 46(4), 257–265. doi:10.1111/j.1744-6163.2010.00253.x.
Furlong, M., & Oei, T. P. S. (2002). Changes to automatic thoughts and dysfunctional attitudes in group CBT for depression. Behavioural and Cognitive Psychotherapy, 30(3), 351–360. doi:10.1017/S1352465802003107.
Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 1. doi:10.1097/QAI.0b013e31822d490a.
Gonzalez, J. S., Peyrot, M., McCarl, L. A., Collins, E. M., Serpa, L., Mimiaga, M. J., & Safren, S. A. (2008). Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care, 31(12), 2398–2403. doi:10.2337/dc08-1341.
Harrell, T. H., & Ryon, N. B. (1983). Cognitive-behavioral assessment of depression: Clinical validation of the automatic thoughts questionnaire. Journal of Consulting and Clinical Psychology, 51(5), 721.
Hill, C. V., Oei, T. P. S., & Hill, M. A. (1989). An empirical investigation of the specificity and sensitivity of the automatic thoughts questionnaire and dysfunctional attitudes scale. Journal of Psychopathology and Behavioral Assessment, 11(4), 291–311.
Hollon, S. D., & Kendall, P. C. (1980). Cognitive self-statements in depression: Development of an automatic thoughts questionnaire. Cognitive Therapy and Research, 4(4), 383–395.
Horberg, M. A., Silverberg, M. J., Hurley, L. B., Towner, W. J., Klein, D. B., Bersoff-Matcha, S., et al. (2008). Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47(3), 384–390.
Ingram, R. E., Kendall, P. C., Siegle, G., Guarino, J., & McLaughlin, S. C. (1995). Psychometric properties of the positive automatic thoughts questionnaire. Psychological Assessment, 7(4), 495.
Ironson, G., O’Cleirigh, C., Fletcher, M. A., Laurenceau, J. P., Balbin, E., Klimas, N., et al. (2005). Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosomatic Medicine, 67(6), 1013–1021. doi:10.1097/01.psy.0000188569.58998.c8.
Kazdin, A. E. (1990). Evaluation of the automatic thoughts questionnaire: Negative cognitive processes and depression among children. Psychological Assessment: A Journal of Consulting and Clinical Psychology, 2(1), 73.
Kelly, J. A., & Amirkhanian, Y. A. (2003). The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe. International Journal of STD & AIDS, 14(6), 361–371.
Kwon, S. M., & Oei, T. P. (1992). Differential causal roles of dysfunctional attitudes and automatic thoughts in depression. Cognitive Therapy and Research, 16(3), 309–328.
Kwon, S. M., & Oei, T. P. S. (2003). Cognitive change processes in a group cognitive behavior therapy of depression. Journal of Behavior Therapy and Experimental Psychiatry, 34(1), 73–85. doi:10.1016/S0005-7916(03)00021-1.
Labbe, A. K., O’Cleirigh, C. M., Stein, M., & Safren, S. A. (2015). Depression CBT treatment gains among HIV-infected persons with a history of injection drug use varies as a function of baseline substance use. Psychology, Health & Medicine, 20(7), 870–877. doi:10.1080/13548506.2014.999809.
Leserman, J. (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosomatic Medicine, 70(5), 539–545.
McIntosh, R. C., Seay, J. S., Antoni, M. H., & Schneiderman, N. (2013). Cognitive vulnerability for depression in HIV. Journal of Affective Disorders, 150(3), 908–915. doi:10.1016/j.jad.2013.05.014.
Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. The British Journal of Psychiatry, 134(4), 382–389.
Moorey, S. (2010). The six cycles maintenance model: Growing a “vicious flower” for depression. Behavioural and Cognitive Psychotherapy, 38(2), 173–184. doi:10.1017/S1352465809990580.
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007). Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet, 370(9590), 851–858.
O’Cleirigh, C., Newcomb, M. E., Mayer, K. H., Skeer, M., Traeger, L., & Safren, S. A. (2013). Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: A longitudinal analysis of data from six sites involved in a “prevention for positives” study. AIDS and Behavior, 17(5), 1764–1769. doi:10.1007/s10461-013-0462-8.
Olatunji, B. O., Mimiaga, M. J., O Cleirigh, C., & Safren, S. A. (2006). A review of treatment studies of depression in HIV. Topics in HIV Medicine, 14(3), 112.
Pence, B. W., Miller, W. C., Whetten, K., Eron, J. J., & Gaynes, B. N. (2006). Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. JAIDS Journal of Acquired Immune Deficiency Syndromes, 42(3), 298–306.
Pomeroy, E. C., Kiam, R., & Green, D. L. (2000). Reducing depression, anxiety, and trauma of male inmates: An HIV/AIDS psychoeducational group intervention. Social Work Research, 24(3), 156–167.
Preacher, K. J., & Coffman, D. L. (2006). Computing power and minimum sample size for RMSEA [Computer software]. http://quantpsy.org/.
Safren, S. A., Bedoya, C. A., O’Cleirigh, C., Biello, K. B., Pinkston, M. M., Stein, M. D., et al. (2016). Treating depression and adherence (CBT-AD) in patients with HIV in care: A three-arm randomized controlled trial. Lancet HIV, (Epub ahead of print.) doi:10.1016/S2352-3018(16)30053-4.
Safren, S. A., Gonzalez, J. S., & Soroudi, N. (2007a). Coping with chronic illness: Cognitive behavioral therapy for adherence and depression, client workbook. NY: Oxford University Press.
Safren, S. A., Gonzalez, J. S., & Soroudi, N. (2007b). Coping with chronic illness: Cognitive behavioral therapy for adherence and depression, therapist guide. NY: Oxford University Press.
Safren, S. A., Gonzalez, J. S., Wexler, D. J., Psaros, C., Delahanty, L. M., Blashill, A. J., et al. (2014). A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care, 37(3), 625–633.
Safren, S. A., O’Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012). Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 80(3), 404–415. doi:10.1037/a0028208.
Safren, S. A., O’Cleirigh, C., Tan, J. Y., Raminani, S. R., Reilly, L. C., Otto, M. W., & Mayer, K. H. (2009). A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28(1), 1–10. doi:10.1037/a0012715.
Safren, S. A., Otto, M. W., & Worth, J. L. (1999). Life-steps: Applying cognitive behavioral therapy to HIV medication adherence. Cognitive and Behavioral Practice, 6(4), 332–341.
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(suppl 20), 22–33.
Shrier, L. A., Harris, S. K., Sternberg, M., & Beardslee, W. R. (2001). Associations of depression, self-esteem, and substance use with sexual risk among adolescents. Preventive Medicine, 33(3), 179–189. doi:10.1006/pmed.2001.0869.
Simoni, J. M., Safren, S. A., Manhart, L. E., Lyda, K., Grossman, C. I., Rao, D., et al. (2011). Challenges in addressing depression in HIV research: Assessment, cultural context, and methods. AIDS and Behavior, 15(2), 376–388. doi:10.1007/s10461-010-9836-3.
Simoni, J. M., Wiebe, J. S., Sauceda, J. A., Huh, D., Sanchez, G., Longoria, V., et al. (2013). A preliminary RCT of CBT-AD for adherence and depression among HIV-positive Latinos on the US-Mexico border: The Nuevo Día study. AIDS and Behavior, 17(8), 2816–2829. doi:10.1007/s10461-013-0538-5.
Smith, J. M., & Alloy, L. B. (2009). A roadmap to rumination: A review of the definition, assessment, and conceptualization of this multifaceted construct. Clinical Psychology Review, 29(2), 116–128. doi:10.1016/j.cpr.2008.10.003.
Tegger, M. K., Crane, H. M., Tapia, K. A., Uldall, K. K., Holte, S. E., & Kitahata, M. M. (2008). The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care and STDs, 22(3), 233–243. doi:10.1089/apc.2007.0092.
Uthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014). Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: A systematic review and meta-analysis. Current HIV/AIDS Reports, 11(3), 291–307. doi:10.1007/s11904-014-0220-1.
Valente, S. M. (2003). Depression and HIV disease. Journal of the Association of Nurses in AIDS care, 14(2), 41–51. doi:10.1177/1055329002250993.
Acknowledgements
Funding for this project came from a National Institute of Mental Health Grant R01MH084757 and a National Institute of Drug Abuse Grant K24DA040489 to Dr. Steven A. Safren.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Kristen E. Riley and Jasper S. Lee have no conflicts of interest. Dr. Steven A. Safren receives royalties from Oxford University Press for books/treatment manuals on treating depression in the context of chronic illness.
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (national and institutional). Informed consent was obtained from all individual subjects participating in the study.
Animal Rights
No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Riley, K.E., Lee, J.S. & Safren, S.A. The Relationship Between Automatic Thoughts and Depression in a Cognitive-Behavioral Treatment for People Living with HIV/AIDS: Exploring Temporality and Causality. Cogn Ther Res 41, 712–719 (2017). https://doi.org/10.1007/s10608-017-9839-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10608-017-9839-8